Key result
The emerging subspecialty of cardio-oncology aims to promote cardiovascular health while facilitating effective cancer therapy, addressing the growing impact of cardiovascular events on cancer survivors.
This review outlines the concepts of cardio-oncology and the importance of specialist teams in managing cardiovascular complications of cancer therapies.
Answers are grounded in this paper and cite their sources.
Supports specialist teams in cancer care; leaves open optimal implementation and outcomes data for prospective validation.
Substantial progress in cancer therapy increasingly allows higher cure rates, and even advanced disease can be stabilized, allowing improved survival with quality of life for months to years, meaning comorbid diseases are a growing determinant of outcome. Cardiovascular events substantially contribute to long-term morbidity and mortality in people living with or surviving cancer. In recognition of this, the subspecialty of cardio-oncology has emerged, and aims to promote cardiovascular heath, whilst facilitating the most effective cancer therapy. This review describes the concept of cardio-oncology, and illustrates the role played by a specialist team in improving outcomes, using heart failure secondary to breast cancer treatment as an example. We aim to highlight pivotal original research and comprehensive summaries of the most relevant topics, providing an overview for cardiologists and oncologists about this increasingly important medical problem.
No takes yet. Share an insight, caveat, or question.
Cubbon et al. (2016) conducted a review in Cancer and cardiovascular disease. The emerging subspecialty of cardio-oncology aims to promote cardiovascular health while facilitating effective cancer therapy, addressing the growing impact of cardiovascular events on cancer survivors.
Synapse has enriched 10 related papers. Consider them for comparative context: